Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of tissue-engineering bone

A tissue-engineered bone, a technology for use, applied in the field of medicine, can solve problems that need to be developed, and achieve the effects of easy access, effective repair and healing, and easy operation

Active Publication Date: 2017-04-26
ACADEMY OF MILITARY MEDICAL SCI +1
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, currently available drugs for bone injury diseases are still to be developed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of tissue-engineering bone
  • Application of tissue-engineering bone
  • Application of tissue-engineering bone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1 Identification of surface markers of mesenchymal stem cells by flow cytometry

[0049] (1) mesenchymal stem cells (cell shape as figure 1 shown) were cultured in a 10 cm cell culture dish containing serum-free medium (purchased from Sanli Company, China). When the cells grow and reach more than 90% confluency, discard the medium and wash the cells once with PBS buffer, add TrypLe Express enzyme to digest the cells, and when the cells become round and fall off the culture plate, use 10% fetal The αMEM medium of bovine serum was digested, and the cell suspension was collected into a 15ml centrifuge tube, and centrifuged at 1200rpm for 5 minutes. After the supernatant was discarded, the cells were resuspended in fresh serum-free medium, subcultured for 3 generations, and the cells of the third generation were taken and digested with trypsin.

[0050] (2) Put the digested mesenchymal stem cells into a 1.5mL EP tube, add 1 μl flow cytometry antibodies (CD73, CD90...

Embodiment 2

[0054] Example 2 Screening of CD51-expressing mesenchymal stem cells

[0055] (1) Culture mesenchymal stem cells in a 10cm cell culture dish containing serum-free medium. When the cells grow and reach more than 90% confluency, discard the medium and wash the cells once with PBS buffer, add TrypLe Express enzyme to digest the cells, and when the cells become round and fall off the culture plate, use 10% fetal The αMEM medium of bovine serum was digested, and the cell suspension was collected into a 15ml centrifuge tube, and centrifuged at 1200rpm for 5 minutes. After the supernatant was discarded, the cells were resuspended in fresh serum-free medium, subcultured for 3 generations, and the cells of the third generation were taken and digested with trypsin.

[0056] (2) Put the digested mesenchymal stem cells into a 1.5mL EP tube, add 10μl CD51 flow cytometry antibody, and incubate at 4°C in the dark for 30 minutes.

[0057] (3) The cells were washed twice with PBS buffer, and...

Embodiment 3

[0059] Example 3 Comparison of osteogenic differentiation of mesenchymal stem cells+pre-induced cells and mesenchymal stem cells

[0060] (1) When the mesenchymal stem cells screened in Example 2 are cultured to 80-90% confluence, the cells are digested with trypsin and counted, and then counted according to 8000 cells / cm 2 Inoculated into 6-well plates (α-MEM medium containing 10% by volume of fetal bovine serum), and then put the cells in 37°C, 5% CO 2 cultured in an incubator.

[0061](2) On the second day, the osteogenic induction medium was replaced, and the medium components were DMEM, 10% fetal bovine serum, 0.1 mM dexamethasone, 10 mM β-sodium glycerophosphate and 50 μM ascorbic acid.

[0062] (3) The medium was changed once every two days, and the cells were induced for 7 days, and the obtained cells were pre-induced cells.

[0063] (4) After 7 days, discard the medium, rinse the cells once with PBS buffer, add TrypLe Express enzyme to digest the cells, and when the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of tissue-engineering bone in preparation of medicines, wherein the medicine is used for treating bone injury diseases. The tissue-engineering bone includes mesenchymal stem cells and pre-induction cells. The tissue-engineering bone has a strong capability of being differentiated into bone cells, is high in yield of the bone cells, and can provides required cells for tissue repair in injured parts of bone and quickly repair and cure the injured parts of bone. The tissue-engineering bone is convenient to prepare and is safe and reliable.

Description

technical field [0001] The present invention relates to the field of medicine. In particular, the invention relates to the use of tissue engineered bone. Background technique [0002] Bone injury often occurs when the fracture fragments pass through the limb during trauma or when the inactive bone is removed during debridement of open fractures, mainly including bone defect and defect repair. Bone injury is a common clinical disease, and it is also one of the difficult problems in orthopedic treatment. [0003] However, currently available drugs for bone injury diseases remain to be developed. Contents of the invention [0004] The present invention aims at solving one of the technical problems existing in the prior art at least to a certain extent. Therefore, the present invention proposes the use of tissue engineered bone in the preparation of medicines. [0005] It should be noted that the present invention is based on the inventor's following findings: [0006] At...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61P19/08
CPCA61K35/28
Inventor 裴雪涛王思涵张静岳文南雪姚海雷贾雅丽张博文
Owner ACADEMY OF MILITARY MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com